Tue, August 15, 2023

Sumant Kulkarni Maintained (zvra) at Strong Buy with Increased Target to $20 on, Aug 15th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-20-on-aug-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Sumant Kulkarni of Canaccord Genuity, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $19 to $20 on, Aug 15th, 2023.

Sumant, nor any peers, have made any analyst calls on ZVRA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30